University of Washington: Neoplasm Metastasis trials

The registry lists 11 Neoplasm Metastasis studies with University of Washington as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 3Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic CancerCompletedNCT05847686Phase 1/2Results posted
• Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)CompletedNCT04283994Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)CompletedNCT04281784Not applicableResults posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• Improving Communication About Serious IllnessCompletedNCT01933789Not applicableResults posted
• Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerCompletedNCT00992602Phase 2Results posted
• Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
• Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic MalignanciesActive, not recruitingNCT07336238Phase 2
• A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic CancerCompletedNCT06644170Phase 1
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04673448Phase 1
• Genetic Testing for Men With Metastatic Prostate CancerTerminatedNCT03503097